GMED logo

Globus Medical Inc. Class A (GMED)

$69.99

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on GMED

Market cap

$9.27B

EPS

4.05

P/E ratio

19

Price to sales

3.19

Dividend yield

--

Beta

0.97843

Price on GMED

Previous close

$70.50

Today's open

$70.25

Day's range

$69.49 - $70.93

52 week range

$69.49 - $101.40

Profile about GMED

CEO

Keith Pfeil

Employees

6000

Headquarters

AUDUBON, PA

Exchange

New York Stock Exchange

Shares outstanding

132471693

Issue type

Common Stock

GMED industries and sectors

Healthcare

Medical Equipment & Supplies

News on GMED

Globus Medical, Inc. (GMED) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Globus Medical, Inc. (GMED) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • 10 hours ago

news preview

Globus Medical to Participate in Jefferies Global Healthcare Conference

AUDUBON, Pa., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Jefferies Global Healthcare Conference in London.

news source

GlobeNewsWire • Nov 9, 2026

news preview

Globus Medical Q3 Earnings Call Highlights

Globus Medical NYSE: GMED lowered its 2026 revenue forecast after third-quarter sales fell, citing continued declines at its Nevro business, delayed spine product launches and lower contributions from competitive sales recruiting.

news source

MarketBeat • Nov 7, 2026

news preview

GMED Q3 Earnings Call Highlights Guidance Cut and 2027 Reset

Globus Medical cuts its 2026 revenue outlook amid spine launch delays and weak Nevro sales while shifting its focus to new products and growth opportunities in 2027.

news source

Zacks Investment Research • Nov 6, 2026

news preview

Globus Medical, Inc. (GMED) Q3 2026 Earnings Call Transcript

Globus Medical, Inc. (GMED) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 6, 2026

news preview

Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program

AUDUBON, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the third quarter ended September 30, 2026.

news source

GlobeNewsWire • Nov 5, 2026

news preview

Compared to Estimates, Globus Medical (GMED) Q3 Earnings: A Look at Key Metrics

The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 6, 2026

news preview

Globus Medical (GMED) Q3 Earnings Top Estimates

Globus Medical (GMED) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.18 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Nov 2, 2026

news preview

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

The consensus price target hints at a 30.5% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

news source

Zacks Investment Research • Nov 2, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Globus Medical Inc. Class A

Open an M1 investment account to buy and sell Globus Medical Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in GMED on M1